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ABSTRACT
This commentary article is co-authored by an
adult patient with X-linked retinoschisis and
two ophthalmologists affiliated with the
University Hospitals Birmingham NHS Foun-
dation Trust. It describes the patient’s experi-
ences of sight loss and the diagnosis and
management of X-linked retinoschisis. The
treating ophthalmologists then draw upon
these experiences and discuss the disease and
associated sight loss in a wider context.
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Key Summary Points
This commentary provides patients and
physicians with unique perspectives on
X-linked retinoschisis.
The patient’s perspective on the process of
diagnosing and managing X-linked
retinoschisis and on living with this
condition from day to day is described.
The physicians’ response to the patient’s
perspective is also provided.
PATIENT’S EXPERIENCE
Like many people, I knew nothing about
blindness; to me, you could either see or you
could not. I was reasonably fit and active, and
was rarely ill—up until the one morning when
everything changed. I got out of bed and just
could not focus. At first, I just thought I was still
sleepy, but the blurring just did not go. I also
had severe headaches and nausea. I went to my
local optician who spotted something unusual
at the back of my eyes, and referred me to my
local specialist ophthalmology unit the same
day at a hospital. Although surprised, I was not
overly concerned at that time.
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I attended the clinic and had several eye
scans over the course of 8 h, each time seeming
to see someone more senior. I knew something
was amiss. I was then told that holes had
appeared at the back of my eyes and further
investigations were required.
From this point, things moved quickly: I was
sent to another eye specialist for more tests and
eventually ended up under the care of special-
ists at a tertiary eye specialist unit. I was worried
that my symptoms could be indicative of a
brain tumour, especially given the sudden onset
of symptoms.
Over the next few months, I underwent a
vast number of tests. I had brain scans, full body
scans, lumbar punctures. Many thoughts went
through my mind, including ‘Am I going to
die?’ and ‘What about my wife and children?’.
My personality began to change; I started feel-
ing anxious, panicking, and having constant
headaches.
Thankfully, when the results came back they
confirmed that I did not have a tumour. It was a
huge weight lifted frommy shoulders. Yes, I was
losing my sight, but at least there was no
imminent threat to my life. My illness was still
unknown, and I underwent a period in hospital
for plasma exchange treatment—not a pleasant
experience, and not without dangers, but well
worth trying. Sadly, my sight continued to
deteriorate, although at a much slower rate than
the first onset. This has left me severely sight
impaired.
The unusual thing about sight loss is that it is
an invisible condition. The only time people
realize is when you use a white cane. Every
aspect of my life has changed.
Two distinct incidents will always stay with
me. The first at an occupational health inter-
view with my ‘disability’ officer. I worked at a
university and expected to be treated with
considerable understanding, but was met with
what I could only describe as hostility. No one
made their way to escort me to the third floor of
a building, showed me to a seat, shook my
hand, or asked if I was okay. The disability
officer began to talk to me, and after a short
time asked ‘How bad are your eyes, as you are
looking at me when I talk to you?’. I felt so
uncomfortable, and had to explain that I could
follow her voice even though I could not see
her. My job at that time relied heavily on eye-
sight—handling chemicals, bacteria and lab
equipment in a congested space. She told me
that there were no other jobs available on
campus at the time, and I should be a dispatcher
at a taxi company as I did not need eyesight to
handle the phone. I felt betrayed: she knew
nothing of me, my capabilities, my education.
Because I was blind, I was stupid and incapable
of nothing more than answering a phone.
Another incident was when a close relative
sarcastically said ‘not bad for a blind man to be
cleaning windows’ when they came around to
my house.
You would be amazed by how many people
assume that if you are blind, you must be deaf.
They shout at you or speak very slowly, and it
can be amusing to play along. It is a myth that
your hearing improves because of sight loss; it is
just that you rely on it more.
I think very often that it is the psychological
effect of sight loss that causes more problems.
With the physical side you learn to adapt. You
do things from memory; it’s surprising how you
subliminally count the number of steps on a
staircase. I also rely on touch hugely—it’s
amazing how your fingertips transmit so much
information. You learn to tell minute differ-
ences in thickness, feel the head of a screw, find
the buttons on a keypad, etc. Mentally though, I
do not think I will ever come completely to
terms with sight loss. It took me a long time to
feel even remotely comfortable asking for help
from anybody; I even hated people offering to
help. I find not being able to recognise faces
upsetting. I have to rely on voices to be able to
work out who they are. It’s amazing how much
you miss not being able to see the microex-
pressions on people’s face. Now I realise those
expressions often tell you more than what
someone is saying.
I have some peripheral vision left, though I
have total night blindness—I cannot see a thing
in low light, or bright light either come to think
of it. It’s so difficult trying to explain to other
people what you can or cannot see, what you
can and cannot do. No two people with sight
loss that I have met have been affected in the
same way. I know that depression affects many
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though; I have heard many people say that they
wanted to end it all! Thankfully, this is not a
sentiment that has ever crossed my mind.
People say that it must be terrible to lose
your sight at my age, but with everything there
are always two ways of looking at things. I am so
thankful that this did not happen to me at an
earlier age. I have done so many things and seen
so much—I have travelled the world, met the
love of my life, witnessed the birth of my two
gorgeous children. Those memories will always
be there.
PHYSICIANS’ RESPONSE
We are grateful to Mr Price-Hunt for sharing his
patient journey.
X-linked retinoschisis (XLRS) is one of the
most common paediatric retinal dystrophies,
with a prevalence ranging from 1 in 5000 to 1 in
20,000 [1]. Due to the genetics of X-linked
conditions, this condition predominantly
affects male patients;female carriers typically do
not present with clinical features [2, 3]. XLRS
leads to schisis (splitting) of the neural retina
and thus to reduced visual acuity in affected
patients. The gene that is affected in this con-
dition is known as RS-1, which encodes for
proteins that are responsible for cell-to-cell
adhesion and are only found in the retina [4].
Mr Price-Hunt’s presentation of XLRS was
unusual and diagnostically challenging. He
presented to us middle-aged (in his late 40s).
This condition can present at different ages, but
primarily affects school-age children [5]. The
delay between the time a patient is referred to
an ophthalmologist and the diagnosis of this
condition can be up to 8.3 years [5]. The degree
of visual impairment is variable and can range
from 20/20 to 20/600 [6].
The clinical features of XLRS are classically
described as small cysts around the fovea with a
spoke-wheel appearance [7]. Other clinical fea-
tures include peripheral retinoschisis in the
inferotemporal region. Additional peripheral
changes include pigmentations that can
resemble retinitis pigmentosa, vitreous veils,
perivascular sheathing, subretinal fibrosis, and
an inner retinal reflex which shows as a tapetal-
like reflex [5].
When Mr Price-Hunt was first referred to us,
he had reductions in vision in both eyes, a best
corrected visual acuity of 6/36 in the right eye
and 6/18 in the left eye, persistent macular
oedema, epiretinal membrane, and a loss of
outer retinal photoreceptors (Fig. 1). There was
no evidence of anterior segment inflammation
or changes.
Cystic changes and macula oedema can be
caused by various conditions, including vein
occlusions, diabetic maculopathy, uveitis,
inherited cystoid macular oedema and retinal
dystrophies such as retinitis pigmentosa. Foveal
schisis in X-linked retinoschisis can lead to
macular oedema and can sometimes be difficult
to distinguish from other clinical causes. Mr
Price-Hunt was also checked extensively for
autoimmune retinopathy (AIR), which can
sometimes present with diffuse retinal atrophy,
macular oedema, and minimal findings on
ophthalmic examination [8]. AIR is a type of
immune-mediated disease caused by circulating
autoantibodies against the retina, which can on
occasion be due to the presence of neoplastic
disease [9]. This was why he had investigations
to rule out neoplastic disease, including full-
body computed tomography (CT) scans, posi-
tron emission tomography (PET) scans, a mag-
netic resonance imaging (MRI) brain scan with
contrast and a cerebrospinal fluid examination
to rule out infection and autoimmune and
demyelinating diseases. He was also treated
empirically with plasmapheresis, which some-
times improves the symptoms of AIR. In diag-
nostically uncertain cases, we sometimes
perform electrodiagnostic testing. This can lead
to nonspecific results, with electroretinogram
(ERG) findings sometimes showing electroneg-
ative b-waves in X-linked retinoschisis, condi-
tions such as AIR, and a variety of other
hereditary and acquired retinal disorders [9, 10].
While we might not be able to alter the course
of the disease, sometimes one of the roles we
have as clinicians is to reassure the patient that
there is no other systemic or life-threatening
condition that is causing the visual loss.
In our experience, we find that it is often
helpful to offer patients genetic testing to
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determine the underlying genetic cause of the
eye disease. While the results of genetic testing
at this point would be unlikely to offer any new
treatment, it can provide patients with a greater
understanding of the underlying disease. From
a practical point of view, the results of the test
could also lead to the testing of other family
members who might want to know if they have
a particular inherited condition. We have an
excellent genetics department at the West
Midlands Regional Clinical Genetics Service in
Birmingham, which processes over 170 genes
associated with the retina. This led to the diag-
nosis of X-linked retinoschisis in the present
case, as the patient was positive for the corre-
sponding RS-1 gene mutation.
We follow up patients every 6–12 months
with an examination and OCT scans to check
for signs of vitreous haemorrhage, retinal
detachment and cystic changes in the retina.
Schisis cavities or cystic changes can sometimes
be successfully treated with topical dorzolamide
[11]. However, it is the patient who has to live
with the realities of sight impairment, including
its associated psychological and physical chal-
lenges. In the UK, we are fortunate to have a
number of great charities to support patients
with sight impairment, such as the Royal
National Institute of Blind People (RNIB) and
the Macular Society [12, 13]. These charities
offer low-vision aids such as equipment to help
patients to continue to read and write and to
perform everyday tasks such as navigating
around the home and kitchen.
Eye care liaison officers (ECLO) function as a
unique bridge for patients to access health and
social services in the UK. ECLOs usually work in
a hospital setting and can help support the
patient’s emotional and mental well-being after
a clinic appointment with an ophthalmologist.
They provide advice on welfare benefits,
remaining in employment, and access to vari-
ous organisations and local support groups.
Fig. 1 Optical coherence tomography showing epiretinal membrane, macular oedema, and a loss of outer retinal photoreceptors
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They are also able to guide the patients through
the process of being registered as sight impaired.
As Mr Price-Hunt rightly pointed out, no two
patients with sight loss are affected in the same
way. In X-linked retinoschisis for example,
there are extreme differences in severity within
families, even amongst affected brothers [14].
This article is based on previously conducted
studies and does not contain any studies with
human participants or animals performed by
any of the authors.
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